France is the 2nd European market for medicines and medical devices

The sector has 3000 companies and a turnover of 90 billion € in 2019

Investment funds have allocated 340 million euros to bio-tech startups

The goal of the transformation of the health system is to be more patient-oriented and improve the quality of life of French people.

Innovation in health concerns:

  • The quality, relevance and modes of financing of care
  • Investments for research (advanced technology, AI, medtechs, biotechs, e-health, etc.)
  • The digitalization of the customer journey through remote medical consultation platforms, shared medical records, etc.
  • Territorial organization for better coordination of public and private actors

In addition, following the health crisis, numerous investments in R&D will be made to relocate the production activities of pharmaceutical laboratories in France.


Among our achievements

Our experts support companies in the sector in developing their innovations and their performance.

Scroll to Top